Pharmaceutical Firm Installs 9.95 MW Solar
KDC Solar commenced commercial operations of its 9.95- MW solar panel system in New Jersey. The system will provide electricity to Eli Lilly and Company’s ImClone biopharmaceutical operations in Branchburg, NJ.
The new system will generate nearly 12.9 million kWh per year. It will provide the primary Lilly manufacturing facility at this location with about 45 percent of its annual electricity needs. KDC Solar developed, owns and will operate the solar panel system.
KDC Solar signed an engineering and construction contract for the installation of the solar project with The Whiting-Turner Contracting Company and SPI Solar. Whiting-Turner was the general contractor, and SPI Solar provided solar panel procurement and oversight.
The solar panel system uses 40,180 PV panels, 16 Advanced Energy Industries 500 kilowatt inverters and is ground-mounted across 43 acres of land owned by a subsidiary of KDC Solar.
- 2016 Environmental Leader Product & Project Awards
- Financing Environmental Resiliency and a Low-Carbon Future with Green Bonds
- eBook: Five Key Considerations for Integrating Renewables into Your Procurement Strategy
- Practical Guide to Transforming Energy Data into Better Buildings
- Operationalizing EHS Management: Bridge the Gap from Strategy to Execution
- The New Energy Future - Challenges and Opportunities in Corporate Energy Management
- Planning for a Sustainable Future
- Improve Occupant Comfort & Reduce Energy Costs Through Humidity Control
- Choosing the Correct Emission Control Technology
- Advanced Rooftop-Unit Control (ARC) Retrofits: Field Demonstrations Validate Energy Savings